USA - NASDAQ:BLRX - US09071M2052 - ADR
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-30 | Jones Trading | Upgrade | Hold -> Buy |
| 2025-05-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-02 | Jones Trading | Downgrade | Buy -> Hold |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-04 | Jones Trading | Initiate | Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-25 | Oppenheimer | Reiterate | Outperform |
The consensus rating for BIOLINERX LTD-SPONS ADR (BLRX) is 100 / 100 . This indicates that analysts generally have a positive outlook on the stock.